News
-
-
-
COMMUNIQUÉ DE PRESSE
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
Bausch Health & Solta Medical announce Thermage technology surpasses 5 million skin treatments. Company's dedication to non-invasive skin tightening solutions reflected in global success -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan
Bausch Health Canada introduces PrCABTREO™ to public drug plans in Quebec and Saskatchewan. CABTREO is a triple-combination topical treatment for acne vulgaris patients -
COMMUNIQUÉ DE PRESSE
Le traitement pour l’acné vulgaire de Bausch Health, Canada Inc., (Pr)CABTREO(MC) (gel de phosphate de clindamycine, d’adapalène et de peroxyde de benzoyle), est maintenant couvert par les régimes publics du Québec et de la Saskatchewan
Bausch Health, Canada Inc. annonce l'ajout de CABTREO aux régimes publics d'assurance médicaments du Québec et de la Saskatchewan pour le traitement de l'acné vulgaire
